Back to search
Familial Hypobetalipoproteinaemia - Heterozygous Form
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Hypobetalipoproteinaemia - Heterozygous Form trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Hypobetalipoproteinaemia - Heterozygous Form trials you may qualify forRationale. ANGPTL3 has been identified as important regulator of lipolysis as well as a determinant of plasma levels of apolipoprotein B-containing lipoproteins…
The pilot study has the target to evaluate the outcomes of two novel mutations in the gene of Apolipoprotein B (ApoB). ApoB is the main part of the low-density…